“In a historic milestone for Bolivia, our El Alto Preclinical Radiopharmacy Cyclotron Complex has begun sovereign production of fluorodeoxyglucose-FDG radiopharmaceuticals for the care of cancer patients in the network of nuclear medicine and radiotherapy centers,” the head of state wrote on Twitter.
Arce assured that the Andean-Amazonian nation is advancing in the application for medical purposes of nuclear techniques based on radioactive compounds now being made “in our homeland.”
Another element that the dignitary highlights on social networks is that those who create these types of elements with advanced technologies are Bolivian professionals.
All of this will be available to the population free of charge through the unified healthcare system, the head of state added.
“We’re entering a new era of using technology to bring hope to our cancer patients,” he said.
The preclinical radiopharmaceutical cyclotron complex installed in District 8 of the city of El Alto began its test phase with the production of radiopharmaceuticals for the diagnosis of cancer and other pathologies.
Such compounds are used in devices such as SPECT/CT (single photon emission computed tomography for imaging).
It is also used in instruments called PET/CT (positron emission tomography-computed tomography).
This latest nuclear medicine technique combines a positron emission tomograph and an X-ray computed tomograph in a single gantry to acquire sequential images from both devices in the same session, which are combined into a single overlapping image.
rgh/jpm